Lightning Round: Excipients 4.0 - Innovations in Novel Stabilization Technology
Conference Theater 1
Track 4: Exploring Excipients
Information
Changing the world one film at a time" At Jurata we are focused on eliminating the need for cold chain storage of vaccines and biologics, including mRNA-LNPs, in order to improve global health equity. Our novel stabalization technology is 10x more efficient to produce than lyophilized products and allows for sublingual and buccal delivery.
